Clinical trial
Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
NCT04117932 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
- Lead sponsor
- CHU de Reims
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 11, 2020
- Completion date
- June 22, 2023
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bullous pemphigoid